scorecardresearch
Wednesday, July 23, 2025
TopicPfizer

Topic: Pfizer

Expert panel seeks additional data on Covid vaccines from Serum Institute, Bharat Biotech

The applications of Bharat Biotech and Serum Institute of India are under consideration, while that of the Indian arm of Pfizer has not yet been taken up.

After HCQ, India pushes vaccine diplomacy in S. Asia as China rushes in with its Covid shots

As Beijing offers its own Sinovac-made vaccine to Pakistan, Sri Lanka, Nepal and Bangladesh, India takes steps to have a locally-made vaccine distributed to friendly nations.

Approval, pricing, distribution — 5 questions India faces before rolling out Covid vaccine

3 firms have applied for emergency use approval, but no clarity yet on if people will get to choose a vaccine, or what the state’s role in procurement will be.

Pfizer Covid shot is highly effective, has no safety concerns, US FDA staff report says

The report offers a first look at the US review of the vaccine ahead of a public meeting Thursday of outside advisers to the agency.

90-year-old Ireland woman becomes first patient to receive Pfizer Covid vaccine

Margaret Keenan became the first person in the world to receive the Pfizer Covid vaccine outside trial conditions after it got the green light in the UK last week.

Govt begins internal review of Pfizer and Serum Covid vaccines, focus on safety & quality

The recommendations on granting of authorisation will be made on three parameters — safety, quality and efficacy. The Drug Controller General of India will take the final decision.

Pricing of Pfizer’s Covid vaccine will depend on advance booking & doses ordered, says firm

Pfizer has become the first pharmaceutical firm to seek emergency use for its Covid-19 vaccine from the Drugs Controller General of India.

Pfizer seeks emergency use approval of its Covid BioNTech vaccine in India

After the nod from UK and Bahrain, the firm has sought permission to import the vaccine for sale and distribution besides waiver on clinical trials in India.

BioNTech founder Ugur Sahin joins world’s 500 richest after UK approves Covid vaccine

BioNTech’s shares have jumped almost 8% this week and are up more than 250% for the year. Sahin is now the 493rd-richest person on the planet with a net worth of $5.1 billion.

Pfizer, BioNTech seek regulatory clearance from EU for Covid vaccine

BioNTech Chief Financial Officer said the company can start shipping the first doses 'within hours' after regulatory clearance.

On Camera

Bihar mimics 19th-century American South. Citizenship is now weaponised to exclude voters

Disenfranchisement by institutional fiat is profoundly undemocratic. The effect of the ECI's new documentary process in Bihar will tilt the scales in favour of the BJP.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.